Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders

Prime ring substituted thyroid receptor antagonists for the treatment of cardiac and metabolic disorders

US Patent 7279593 · Granted Oct 9, 2007

Estimated economic value: $53,996,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Inhibitors of metallo-beta-lactamases2022
Diarylmethylidene piperidine derivatives and their use as delta opoid receptor a2018
Estrogen receptor ligands2017
Quinoline derivatives and their use as tyrosine kinase inhibitors2015
Estrogen receptor ligands2014
Spiro azepane-oxazolidinones as Kv1.3 potassium channel blockers2013
Quinoline derivatives and their use as tyrosine kinase inhibitors2013
Thyroid receptor ligands2012
Thyroid receptor ligands2012
Sulfonyl-indole derivatives2012
Tricyclic compounds, compositions, and methods useful in the treatment or prophy2011
Benzofuran compounds2010